Estrogen Antagonists: all 386 studies that test it
Page 2 of 4. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.
- Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female SubjectsCompletedNCT01189500Phase 4Results posted
- Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?CompletedNCT01166958Phase 4Results posted
- Hypogonadism in Young Men With Type 2 DiabetesTerminatedNCT01155518Phase 2Results posted
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast CancerCompletedNCT01124695Phase 2Results posted
- Assessment of Multiple Intrauterine Gestations From Ovarian StimulationCompletedNCT01044862Phase 3Results posted
- Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer PatientsCompletedNCT01027416Not applicableResults posted
- Traditional Clomiphene Citrate Administration vs. Stair-step ApproachCompletedNCT01008319Phase 3Results posted
- Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis CongenitaTerminatedNCT01001598Phase 1/2Results posted
- Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast CancerCompletedNCT00999921Phase 4Results posted
- Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)TerminatedNCT00953771Phase 2Results posted
- 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in SituCompletedNCT00952731Phase 2Results posted
- Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving TamoxifenCompletedNCT00764322Phase 2Results posted
- Nutritional Supplements and Hormonal Manipulations for Breast Cancer PreventionCompletedNCT00723398Not applicableResults posted
- Pregnancy in Polycystic Ovary Syndrome IICompletedNCT00719186Phase 3Results posted
- Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy TreatmentCompletedNCT00710970Phase 2Results posted
- To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical TestosteroneCompletedNCT00706719Phase 2Results posted
- Cognition in the Study of Tamoxifen and RaloxifeneCompletedNCT00687102Phase 3Results posted
- Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02CompletedNCT00659373Phase 3Results posted
- Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral DensityCompletedNCT00431444Phase 4Results posted
- Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian SyndromeCompletedNCT00427700Phase 3Results posted
- Raloxifene for Women With Alzheimer's DiseaseCompletedNCT00368459Phase 2Results posted
- Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic AcidCompletedNCT00295646Phase 3Results posted
- Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast CancerCompletedNCT00293540Phase 3Results posted
- Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in SituCompletedNCT00290745Phase 1/2Results posted
- Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in SituTerminatedNCT00290654Phase 2Results posted
- Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory DysfunctionCompletedNCT00213148Phase 2Results posted
- Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast CancerCompletedNCT00201851Phase 3Results posted
- A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)TerminatedNCT00183963Phase 2Results posted
- Tamoxifen and Bortezomib to Treat Recurrent Brain TumorsCompletedNCT00108069Phase 2Results posted
- Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In SituCompletedNCT00072462Phase 3Results posted
- Sulindac and Tamoxifen in Treating Patients With Desmoid TumorCompletedNCT00068419Phase 2Results posted
- Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerCompletedNCT00066690Phase 3Results posted
- Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00041080Phase 3Results posted
- Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneCompletedNCT00036270Phase 3Results posted
- Raloxifene and Rimostil for Perimenopause-Related DepressionCompletedNCT00030147Phase 4Results posted
- Clomiphene Citrate Alone Versus Clomiphene Plus Metformin as First Line Approach for the Treatment of Anovulation in Infertile Patients With Polycystic Ovary SyndromeCompletedNCT07872501Not applicable
- SHORTened Duration of TAMoxifenActive, not recruitingNCT07806630Phase 2
- Letrozole vs. Clomiphene Citrate Plus Tamoxifen for Ovulation Induction and Pregnancy Outcomes.Active, not recruitingNCT07616973Phase 3
- Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS CaseCompletedNCT06813118Phase 1
- Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialSuspendedNCT06671912Phase 3
- One-shot Ovarian Stimulation Protocol (One-shot)CompletedNCT06635538Not applicable
- Clomiphene Citrate in Infertile Men With Idiopathic OligoasthenozoospermiaCompletedNCT06564961Phase 3
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceActive, not recruitingNCT06492616Phase 3
- Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.Active, not recruitingNCT06449027Phase 3
- Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTionCompletedNCT06033092Phase 2
- Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast CancerActive, not recruitingNCT05780567Phase 3
- CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian PopulationStatus unknownNCT05501158Not applicable
- Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast CancerActive, not recruitingNCT05463601Phase 2
- Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With OsteopeniaCompletedNCT05386784Phase 4
- Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian CancerActive, not recruitingNCT05156892Phase 1
- Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast CancerCompletedNCT05150652Phase 2
- Therapeutic Dose Monitoring (TDM) of TamoxifenStatus unknownNCT05133674Phase 2
- Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene CitrateWithdrawnNCT05096169Phase 2
- Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.Status unknownNCT05016349Phase 3
- Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer PatientsActive, not recruitingNCT04997941Phase 2
- Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376Active, not recruitingNCT04961632Phase 1
- Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot TrialWithdrawnNCT04933240Phase 4
- Tamoxifen Therapy for Myotubular MyopathyTerminatedNCT04915846Phase 1/2
- Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.CompletedNCT04757532Phase 1
- Effect of Naringenin and Beta Carotene on Energy ExpenditureCompletedNCT04697355Not applicable
- The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary FibrosisTerminatedNCT04638517Phase 2
- The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT04481282Phase 2
- Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome CoronavirusStatus unknownNCT04389580Phase 2
- BMI Effect on the Response to Ovulation Induction in Letrozole vs ClomidStatus unknownNCT04331197Phase 4
- A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With ThrombocytopeniaStatus unknownNCT04324060Phase 2/3
- Thin Endometrium Undergoing Frozen-thawed Embryo TransferStatus unknownNCT04292886Not applicable
- Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune ThrombocytopeniaStatus unknownNCT04289207Phase 2
- Incremental Clomiphene Citrate Doses in Successive Cycles and FSH, LH and Steroid Hormone LevelsCompletedNCT04210765Phase 4
- A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent GlioblastomaWithdrawnNCT04200066Phase 1
- Added Value of N Acetyle Cysteine to Clomiphene Citrate in PCOCompletedNCT04170439Not applicable
- Mild Stimulation Protocol Using Clomiphene Citrate for Women With PCOS Undergoing in Vitro FertilizationActive, not recruitingNCT04157725Phase 4
- Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One BreastActive, not recruitingNCT04009044Phase 2
- Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary SyndromeStatus unknownNCT03989024Phase 4
- Limited Adjuvant Endocrine Therapy for Low Risk Breast CancerActive, not recruitingNCT03917082Phase 2
- Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 MutationStatus unknownNCT03879174Phase 2
- Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive ExpressionCompletedNCT03870399Phase 2
- Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to TelomeropathyStatus unknownNCT03710356Phase 1/2
- Comparative Antiresorptive Efficacy Discontinuation of DenosumabActive, not recruitingNCT03623633Phase 4
- Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm CellsWithdrawnNCT03615547Phase 3
- Effect of Danazol on Endometrial αvβ3 Integrin Expression in Patients With Unexplained Recurrent Implantation FailureCompletedNCT03563664Phase 3
- The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03460808Phase 1/2
- Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in WomenCompletedNCT03418831Phase 4
- Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian ResponseStatus unknownNCT03400722Phase 4
- Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary SyndromeStatus unknownNCT03396380Phase 3
- Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast CancerStatus unknownNCT03373708Phase 2/3
- Tamoxifen in Duchenne Muscular DystrophyCompletedNCT03354039Phase 3
- Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing LaparoscopyCompletedNCT03352076Phase 2
- Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOSStatus unknownNCT03316469Not applicable
- Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnNCT03238703Phase 4
- The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast CancersStatus unknownNCT03211572Phase 2
- Clomiphene Citrate Stair-Step ProtocolStatus unknownNCT03178500Not applicable
- Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryWithdrawnNCT03147196Phase 2
- Treatment With Tamoxifen in Cryptococcal MeningitisCompletedNCT03112031Phase 2
- The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.Status unknownNCT03060304Phase 4
- Raloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderCompletedNCT03043820Phase 3
- Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping SettingCompletedNCT03028532Phase 1
- Osteoporosis Treatment in Post-menopausal WomenStatus unknownNCT03006003Phase 4
- Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer PatientsCompletedNCT02995772Phase 3
- Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid ArthritisCompletedNCT02982083Not applicable
- Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.CompletedNCT02866955Phase 2